» Articles » PMID: 17131042

Curcumin Attenuates Glutamate-induced HT22 Cell Death by Suppressing MAP Kinase Signaling

Overview
Publisher Springer
Specialty Biochemistry
Date 2006 Nov 30
PMID 17131042
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Glutamate induces cell death by upsetting the cellular redox homeostasis, termed oxidative glutamate toxicity, in a mouse hippocampal cell line, HT22. Extracellular signal-regulated kinases (ERK) 1/2 are known key players in this process. Here we characterized the roles of both MAP kinases and cell cycle regulators in mediating oxidative glutamate toxicity and the neuroprotective mechanisms of curcumin in HT22 cells. c-Jun N-terminal kinase (JNK) and p38 kinase were activated during the glutamate-induced HT22 cell death, but at a later stage than ERK activation. Treatment with a JNK inhibitor, SP600125, or a p38 kinase inhibitor, SB203580, partly attenuated this cell death. Curcumin, a natural inhibitor of JNK signaling, protected the HT22 cells from glutamate-induced death at nanomolar concentrations more efficiently than SP600125. These doses of curcumin affected neither the level of intracellular glutathione nor the level of reactive oxygen species, but inactivated JNK and p38 significantly. Moreover, curcumin markedly upregulated a cell-cycle inhibitory protein, p21cip1, and downregulated cyclin D1 levels, which might help the cell death prevention. Our results suggest that curcumin has a neuroprotective effect against oxidative glutamate toxicity by inhibiting MAP kinase signaling and influencing cell-cycle regulation.

Citing Articles

Neuroprotective Potential of Pyranocoumarins from Nakai on Glutamate-Induced Hippocampal Cell Death.

Tran N, Trinh T, Pyo J, Kim C, Park J, Kang K Antioxidants (Basel). 2023; 12(8).

PMID: 37627646 PMC: 10451762. DOI: 10.3390/antiox12081651.


Sargachromenol Isolated from Attenuates Glutamate-Induced Neuronal Cell Death and Oxidative Stress through Inhibition of MAPK/NF-κB and Activation of Nrf2/HO-1 Signaling Pathway.

Han E, Zhang C, Kim H, Kim J, Park S, Jung W Mar Drugs. 2022; 20(11).

PMID: 36421988 PMC: 9695719. DOI: 10.3390/md20110710.


Nutritional Supplements for the Treatment of Neuropathic Pain.

Abdelrahman K, Hackshaw K Biomedicines. 2021; 9(6).

PMID: 34199290 PMC: 8231824. DOI: 10.3390/biomedicines9060674.


Potential protective roles of phytochemicals on glutamate-induced neurotoxicity: A review.

Afshari A, Fanoudi S, Rajabian A, Sadeghnia H, Mollazadeh H, Hosseini A Iran J Basic Med Sci. 2020; 23(9):1113-1123.

PMID: 32963732 PMC: 7491505. DOI: 10.22038/ijbms.2020.43687.10259.


(L.) . Extract protects against glutamate toxicity and increases the longevity of .

Brimson J, Prasanth M, Plaingam W, Tencomnao T J Tradit Complement Med. 2020; 10(5):460-470.

PMID: 32953562 PMC: 7484969. DOI: 10.1016/j.jtcme.2019.10.001.


References
1.
Hwang C, Ryu Y, Chung M, Kim K, Park S, Chae S . Thioredoxin modulates activator protein 1 (AP-1) activity and p27Kip1 degradation through direct interaction with Jab1. Oncogene. 2004; 23(55):8868-75. DOI: 10.1038/sj.onc.1208116. View

2.
Coyle J, Puttfarcken P . Oxidative stress, glutamate, and neurodegenerative disorders. Science. 1993; 262(5134):689-95. DOI: 10.1126/science.7901908. View

3.
Davis J, Maher P . Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line. Brain Res. 1994; 652(1):169-73. DOI: 10.1016/0006-8993(94)90334-4. View

4.
Runden E, Seglen P, Haug F, Ottersen O, Wieloch T, Shamloo M . Regional selective neuronal degeneration after protein phosphatase inhibition in hippocampal slice cultures: evidence for a MAP kinase-dependent mechanism. J Neurosci. 1998; 18(18):7296-305. PMC: 6793243. View

5.
Xia Z, Dickens M, Raingeaud J, Davis R, Greenberg M . Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 1995; 270(5240):1326-31. DOI: 10.1126/science.270.5240.1326. View